
|Articles|June 27, 2022
This Week on NeurologyLive® — June 27, 2022
Author(s)NeurologyLive® Staff
Here's what is coming soon to NeurologyLive®.
Advertisement
Every week, the NeurologyLive® staff prepares this preview of what to expect from our coverage. This week on NeurologyLive®, there are a number of hot topics that we will be posting on the website. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!
Click through the slides below to see what you can expect from our team this week:
—————————————————
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 VALOR Data Further Supports Tofersen’s Impact on ALS Disease Progression, Survival
2
Patients Treated With REGENXBIO’s DMD Gene Therapy RGX-202 Exceed Expected Disease Trajectory on NSAA
3
sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis
4
FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease
5



























